ALEXANDRIA, Va., March 31 -- United States Patent no. 12,589,124, issued on March 31, was assigned to PRECISIONBIOTICS GROUP Ltd. (Cork, Ireland).
"Bifidobacterium longum" was invented by David Groeger (County Cork, Ireland) and Barry Kiely (County Cork, Ireland).
According to the abstract* released by the U.S. Patent & Trademark Office: "Bifidobacterium longum strains and cell wall fractions isolated from Bifidobacterium longum strains are useful in the prophylaxis or treatment of an infection in a subject caused by a coronavirus such as SARS-CoV-2. They are also useful in the prophylaxis of a secondary bacterial infection associated with an infection in a subject caused by a coronavirus, especially a subject who is susceptible to respir...